Reni J. Benjamin

Stock Analyst at JMP Securities

(2.47)
# 2,499
Out of 5,042 analysts
10
Total ratings
50%
Success rate
16.74%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Reni J. Benjamin

Summit Therapeutics
Oct 20, 2025
Reiterates: Market Outperform
Price Target: $40
Current: $19.28
Upside: +107.47%
Kura Oncology
Oct 20, 2025
Reiterates: Market Outperform
Price Target: $24
Current: $9.70
Upside: +147.42%
Inhibrx Biosciences
Aug 22, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $57.29
Upside: -
Werewolf Therapeutics
Aug 21, 2025
Maintains: Market Outperform
Price Target: $4$3
Current: $1.77
Upside: +69.49%
Prelude Therapeutics
Aug 18, 2025
Maintains: Market Outperform
Price Target: $4$3
Current: $1.62
Upside: +85.19%
BioAtla
Aug 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $0.76
Upside: -
Bicycle Therapeutics
Aug 12, 2025
Maintains: Market Outperform
Price Target: $22$10
Current: $7.88
Upside: +26.90%